Generation of human β-thalassemia induced pluripotent cell lines by reprogramming of bone marrow-derived mesenchymal stromal cells using modified mRNA

Cellular Reprogramming

Volumn 16, Issue 6, 2014, Pages 447-455

  Varela, Ioanna ^a   Karagiannidou, Angeliki ^a   Oikonomakis, Vasilis ^b   Tzetis, Maria ^b   Tzanoudaki, Marianna ^a   Siapati, Elena Konstantina ^c   Vassilopoulos, George ^c   Graphakos, Stelios ^a   Kanavakis, Emmanuel ^a,b   Goussetis, Evgenios ^a  

^a AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c BIOMEDICAL RESEARCH FOUNDATION   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; KRUPPEL LIKE FACTOR 4; LIN28 PROTEIN; MESSENGER RNA; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BETA THALASSEMIA; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CELL DIFFERENTIATION; CELL LINEAGE; COLONY FORMATION; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; EMBRYOID BODY; EMBRYONIC STEM CELL; GENE EXPRESSION PROFILING; GENETIC STABILITY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PLURIPOTENT STEM CELL; TERATOMA; TRANSGENE; CELL LINE; CYTOLOGY; FIBROBLAST; GENETICS; MESENCHYMAL STROMA CELL; NUCLEAR REPROGRAMMING;

BETA-THALASSEMIA; CELL DIFFERENTIATION; CELL LINE; CELLULAR REPROGRAMMING; COMPARATIVE GENOMIC HYBRIDIZATION; FIBROBLASTS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MESENCHYMAL STROMAL CELLS; RNA, MESSENGER; TRANSCRIPTION FACTORS;

EID: 84914110837     PISSN: 21524971     EISSN: 21524998     Source Type: Journal    
DOI: 10.1089/cell.2014.0050     Document Type: Article

References (29)

1. Aziz, A., Soucie, E., Sarrazin, S., and Sieweke, M.H. (2009). MafB/c-Maf deficiency enables self-renewal of differentiated functional macrophages. Science 326, 867-871
2. Bar-Nur, O., Russ, H.A., Efrat, S., and Benvenisty, N. (2011). Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet beta cells. Cell Stem Cell 9, 17-23
3. Choi, K.D., Yu, J., Smuga-Otto, K., Salvagiotto, G., Rehrauer, W., Vodyanik, M., Thomson, J., and Slukvin, I. (2009). Hematopoietic and endothelial differentiation of human induced pluripotent stem cells. Stem Cells 27, 559-567
4. de Carvalho Rodrigues, D., Asensi, K.D., Vairo, L., Azevedo-Pereira, R.L., Silva, R., Rondinelli, E., Goldenberg, R.C., Campos de Carvalho, A.C., and Urmenyi, T.P. (2012). Human menstrual blood-derived mesenchymal cells as a cell source of rapid and efficient nuclear reprogramming. Cell Transplant. 21, 2215-2224
5. Doulatov, S., Vo, L.T., Chou, S.S., Kim, P.G., Arora, N., Li, H., Hadland, B.K., Bernstein, I.D., Collins, J.J., Zon, L.I., and Daley, G.Q. (2013). Induction of multipotential hematopoietic progenitors from human pluripotent stem cells via respecification of lineage-restricted precursors. Cell Stem Cell 13, 459-470
6. Fan, Y., Luo, Y., Chen, X., Li, Q., and Sun, X. (2012). Generation of human beta-Thalassemia induced pluripotent stem cells from amniotic fluid cells using a single excisable lentiviral stem cell cassette. J. Reprod. Dev. 58, 404-409
7. Feng, Q., Lu, S.J., Klimanskaya, I., Gomes, I., Kim, D., Chung, Y., Honig, G.R., Kim, K.S., and Lanza, R. (2010). Hemangioblastic derivatives from human induced pluripotent stem cells exhibit limited expansion and early senescence. Stem Cells 28, 704-712
8. Garcon, L., Ge, J., Manjunath, S.H., Mills, J.A., Apicella, M., Parikh, S., Sullivan, L.M., Podsakoff, G.M., Gadue, P., French, D.L., Mason, P.J., Bessler, M., and Weiss, M.J. (2013). Ribosomal and hematopoietic defects in induced pluripotent stem cells derived from Diamond Blackfan anemia patients. Blood 122, 912-921
9. Haniffa, M.A., Collin, M.P., Buckley, C.D., and Dazzi, F. (2009). Mesenchymal Stem Cells: The Fibroblasts New Clothes? Haematologica 94, 258-263
10. Heng, B.C., Heinimann, K., Miny, P., Iezzi, G., Glatz, K., Scherberich, A., Zulewski, H., and Fussenegger, M. (2013). mRNA transfection-based, feeder-free, induced pluripotent stem cells derived from adipose tissue of a 50-year-old patient. Metab. Eng. 18, 9-24
11. Kim, D., Kim, C.H., Moon, J.I., Chung, Y.G., Chang, M.Y., Han, B.S., Ko, S., Yang, E., Cha, K.Y., Lanza, R., and Kim, K.S. (2009). Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 4, 472-476
12. Kim, K., Doi, A., Wen, B., Ng, K., Zhao, R., Cahan, P., Kim, J., Aryee, M.J., Ji, H., Ehrlich, L.I., Yabuuchi, A., Takeuchi, A., Cunniff, K.C., Hongguang, H., McKinney-Freeman, S., Naveiras, O., Yoon, T.J., Irizarry, R.A., Jung, N., Seita, J. et al. (2010). Epigenetic memory in induced pluripotent stem cells. Nature 467, 285-290
13. Kim, K., Zhao, R., Doi, A., Ng, K., Unternaehrer, J., Cahan, P., Huo, H., Loh, Y.H., Aryee, M.J., Lensch, M.W., Li, H., Collins, J.J., Feinberg, A.P., and Daley, G.Q. (2011). Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells. Nat. Biotechnol. 29, 1117-1119
14. Lengerke, C., Grauer, M., Niebuhr, N.I., Riedt, T., Kanz, L., Park, I.H., and Daley, G.Q. (2009). Hematopoietic development from human induced pluripotent stem cells. Ann. NY Acad. Sci. 1176, 219-227
15. Ma, N., Liao, B., Zhang, H., Wang, L., Shan, Y., Xue, Y., Huang, K., Chen, S., Zhou, X., Chen, Y., Pei, D., and Pan, G. (2013). Transcription activator-like effector nuclease (TALEN)-mediated gene correction in integration-free beta-Thalassemia induced pluripotent stem cells. J. Biol. Chem. 288, 34671-34679
16. Miyoshi, N., Ishii, H., Nagano, H., Haraguchi, N., Dewi, D.L., Kano, Y., Nishikawa, S., Tanemura, M., Mimori, K., Tanaka, F., Saito, T., Nishimura, J., Takemasa, I., Mizushima, T., Ikeda, M., Yamamoto, H., Sekimoto, M., Doki, Y., and Mori, M. (2011). Reprogramming of mouse and human cells to pluripotency using mature microRNAs. Cell Stem Cell 8, 633-638
17. Muller, L.U., Milsom, M.D., Harris, C.E., Vyas, R., Brumme, K.M., Parmar, K., Moreau, L.A., Schambach, A., Park, I.H., London, W.B., Strait, K., Schlaeger, T., Devine, A.L., Grassman, E., DAndrea, A., Daley, G.Q., and Williams, D.A. (2012). Overcoming reprogramming resistance of Fanconi anemia cells. Blood 119, 5449-5457
18. Ng, E.S., Davis, R., Stanley, E.G., and Elefanty, A.G. (2008). A protocol describing the use of a recombinant protein-based, animal product-free medium (APEL) for human embryonic stem cell differentiation as spin embryoid bodies. Nat. Protoc. 3, 768-776
19. Ohnishi, H., Oda, Y., Aoki, T., Tadokoro, M., Katsube, Y., Ohgushi, H., Hattori, K., and Yuba, S. (2012). A comparative study of induced pluripotent stem cells generated from frozen, stocked bone marrow- And adipose tissue-derived mesenchymal stem cells. J. Tiss. Eng. Regen. Med. 6, 261-271
20. Papapetrou, E.P., Lee, G., Malani, N., Setty, M., Riviere, I., Tirunagari, L.M., Kadota, K., Roth, S.L., Giardina, P., Viale, A., Leslie, C., Bushman, F.D., Studer, L., and Sadelain, M. (2011). Genomic safe harbors permit high beta-globin transgene expression in thalassemia induced pluripotent stem cells. Nat. Biotechnol. 29, 73-78
21. Park, I.H., Arora, N., Huo, H., Maherali, N., Ahfeldt, T., Shimamura, A., Lensch, M.W., Cowan, C., Hochedlinger, K., and Daley, G.Q. (2008). Disease-specific induced pluripotent stem cells. Cell 134, 877-886
22. Polo, J.M., Liu, S., Figueroa, M.E., Kulalert, W., Eminli, S., Tan, K.Y., Apostolou, E., Stadtfeld, M., Li, Y., Shioda, T., Natesan, S., Wagers, A.J., Melnick, A., Evans, T., and Hochedlinger, K. (2010). Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nat. Biotechnol. 28, 848-855
23. Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., and Yamanaka, S. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861-872
24. Vitaloni, M., Pulecio, J., Bilic, J., Kuebler, B., Laricchia-Robbio, L., and Izpisua Belmonte, J.C. (2014). MicroRNAs contribute to induced pluripotent stem cell somatic donor memory. J. Biol. Chem. 289, 2084-2098
25. Wang, Y., Zheng, C.G., Jiang, Y., Zhang, J., Chen, J., Yao, C., Zhao, Q., Liu, S., Chen, K., Du, J., Yang, Z., and Gao, S. (2012). Genetic correction of beta-Thalassemia patient-specific iPS cells and its use in improving hemoglobin production in irradiated SCID mice. Cell Res. 22, 637-648
26. Warren, L., Manos, P.D., Ahfeldt, T., Loh, Y.H., Li, H., Lau, F., Ebina, W., Mandal, P.K., Smith, Z.D., Meissner, A., Daley, G.Q., Brack, A.S., Collins, J.J., Cowan, C., Schlaeger, T.M., and Rossi, D.J. (2010). Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 7, 618-630
27. Ye, L., Chang, J.C., Lin, C., Sun, X., Yu, J., and Kan, Y.W. (2009a). Induced pluripotent stem cells offer new approach to therapy in thalassemia and sickle cell anemia and option in prenatal diagnosis in genetic diseases. Proc. Natl. Acad. Sci. USA 106, 9826-9830
28. Ye, Z., Zhan, H., Mali, P., Dowey, S., Williams, D.M., Jang, Y.Y., Dang, C.V., Spivak, J.L., Moliterno, A.R., and Cheng, L. (2009b). Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders. Blood 114, 5473-5480
29. Zou, J., Mali, P., Huang, X., Dowey, S.N., and Cheng, L. (2011). Site-specific gene correction of a point mutation in human iPS cells derived from an adult patient with sickle cell disease. Blood 118, 4599-4608